Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1 5Phase 1/2 4Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 10Glioma 9Glioblastoma 8Sarcoma 7Pancreatic Neoplasms 6Neoplasms 6Neoplasm Metastasis 6Brain Neoplasms 5Recurrence 4Neuroendocrine Tumors 4Neuroblastoma 4Lymphoma 4Lung Neoplasms 4Head and Neck Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Melanoma 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Smoldering Multiple Myeloma 2Smoking Cessation 2Smoking 2Skin Neoplasms 2Sarcoma, Alveolar Soft Part 2

Interventions

Zymosan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Active not recruiting × Neoplasm, Residual × Clear all
NCT04674306 2025-05-23

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Active not recruiting
35 enrolled
Breast

Neoplasm, Residual, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡